1. |
|
|
2. | |
|
3. | |
|
4. | |
|
5. | |
|
6. | |
|
7. | |
|
8. | |
|
9. | |
|
10. | |
|
11. | |
|
12. | |
|
13. | |
|
14. | |
|
15. | |
|
16. | |
|
17. |
Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system. | Nishizono, A; Hiraga, M; Mifune, K; Terao, H; Fujioka, T; Nasu, M; Goto, T; Misumi, J; Moriyama, M; Arakawa, Y; | |
| |
|
18. | |
|
19. |
Carnitine status and safety after administration of S-1108, a new oral cephem, to patients. | Shimizu, K; Saito, A; Shimada, J; Ohmichi, M; Hiraga, Y; Inamatsu, T; Shimada, K; Tanimura, M; Fujita, Y; Nishikawa, T; | |
| |
|
20. | |
|
|